Published: 16 September 2023
Author(s): Kathleen Jahn, Meropi Karakioulaki, Desiree M. Schumann, Hans H. Hirsch, Karoline Leuzinger, Leticia Grize, Stefano Aliberti, Giovanni Sotgiu, Michael Tamm, Daiana Stolz
Issue: March 2024
Section: Original article

BAL leads to changes in management in the majority of immunosuppressed patients. There is a high prevalence of multimicrobial infections and respiratory viral infections in immunocompromised patients with respiratory symptoms. Individual virus infection is associated with diverse risk of a negative outcome.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.